Fantasia Heidi Collins, Harris Allyssa L
Nurs Womens Health. 2015 Jun-Jul;19(3):266-70. doi: 10.1111/1751-486X.12209.
Safe medication use by women during pregnancy and lactation is an area of concern for women and their health care providers. In December 2014, the U.S. Food and Drug Administration (FDA) issued a final rule on new labeling changes, which go into effect in June 2015 and eliminate the current letter system of A-D, X. The new labeling will include a summary of risks to using the medication during pregnancy and lactation, and supporting data and relevant information to assist health care providers in counseling pregnant and lactating women.
孕期和哺乳期女性安全用药是女性及其医疗保健提供者关注的领域。2014年12月，美国食品药品监督管理局（FDA）发布了关于新标签变更的最终规定，该规定于2015年6月生效，取消了现行的A-D、X字母系统。新标签将包括在孕期和哺乳期使用该药物的风险总结，以及支持数据和相关信息，以帮助医疗保健提供者为孕妇和哺乳期妇女提供咨询。
